Nestle India to Drive Volume Growth and Expand Premium Offerings, CMD Reveals

In a strategic move to bolster its market presence amidst inflationary pressures, Nestle India, under the leadership of Chairman and Managing Director Suresh Narayanan, has announced a focused drive towards volume growth. The FMCG giant is setting its sights on enhancing its footprint across India, aiming to increase its touchpoints from the current 51 lakh to 60 lakh within the next four to five years.

Representative image

Nestle India's ambition doesn't stop at expanding its reach. The company is also venturing further into the premium product segment, with plans to make premium offerings, including Nespresso and health science products, contribute to 20% of its sales in the long term. This move is underscored by the opening of the first Nespresso boutique in Delhi later this year, marking a significant step in catering to the upscale coffee market.

The company's strategy is not just about expansion but also deepening its market penetration. Narayanan highlighted the impressive growth from 2016 to 2022, where volume growth was nearly 8-9% out of a total growth of 11-12%. For the quarter ended March 31, 2024, Nestle India reported approximately 9% domestic sales growth, with underlying volume growth at about 4-5%.

Addressing the challenges posed by inflation, Narayanan acknowledged the impact on consumer behavior, noting a tendency to postpone discretionary purchases. Despite these challenges, Nestle India remains optimistic, with an eye on the monsoon season and the formation of a new government to potentially boost market conditions.

The premium product category currently accounts for 12-13% of Nestle India's sales. Narayanan expressed his intention to increase this figure to 15-16% in the medium term and ultimately reach the 20% target. The inclusion of Nespresso capsules in the European Free Trade Agreement, which will see import duties drop to zero from 100% over the next decade, is expected to further fuel this ambition.

On the health science front, Nestle India has entered into a joint venture with Dr. Reddy's to expand its reach in this lucrative segment. The partnership aims to leverage Dr. Reddy's strong presence in the pharmaceutical sector to tap into a market opportunity exceeding Rs 23,000 crore-Rs 24,000 crore. In this joint venture, Dr. Reddy's will hold a 51% stake while Nestle will own the remaining 49%, with an option for Nestle to increase its stake after six years.

Narayanan's vision for Nestle India is clear: to drive volume growth through increased distribution and by tapping into premium segments. With strategic partnerships and an emphasis on premium products like Nespresso and health science offerings, Nestle India is poised for robust growth in the coming years.